Correlation Between Hillstream Biopharma and Unicycive Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Hillstream Biopharma and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Hillstream Biopharma and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Hillstream Biopharma and Unicycive Therapeutics, you can compare the effects of market volatilities on Hillstream Biopharma and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Hillstream Biopharma with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Hillstream Biopharma and Unicycive Therapeutics.

Diversification Opportunities for Hillstream Biopharma and Unicycive Therapeutics

-0.42
  Correlation Coefficient

Very good diversification

The 3 months correlation between Hillstream and Unicycive is -0.42. Overlapping area represents the amount of risk that can be diversified away by holding Hillstream Biopharma and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Hillstream Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Hillstream Biopharma are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Hillstream Biopharma i.e., Hillstream Biopharma and Unicycive Therapeutics go up and down completely randomly.

Pair Corralation between Hillstream Biopharma and Unicycive Therapeutics

Given the investment horizon of 90 days Hillstream Biopharma is expected to generate 1.27 times more return on investment than Unicycive Therapeutics. However, Hillstream Biopharma is 1.27 times more volatile than Unicycive Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Unicycive Therapeutics is currently generating about 0.03 per unit of risk. If you would invest  44.00  in Hillstream Biopharma on August 28, 2024 and sell it today you would lose (5.00) from holding Hillstream Biopharma or give up 11.36% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy31.52%
ValuesDaily Returns

Hillstream Biopharma  vs.  Unicycive Therapeutics

 Performance 
       Timeline  
Hillstream Biopharma 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Hillstream Biopharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable essential indicators, Hillstream Biopharma is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Unicycive Therapeutics 

Risk-Adjusted Performance

14 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Unicycive Therapeutics are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak fundamental indicators, Unicycive Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.

Hillstream Biopharma and Unicycive Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Hillstream Biopharma and Unicycive Therapeutics

The main advantage of trading using opposite Hillstream Biopharma and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Hillstream Biopharma position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.
The idea behind Hillstream Biopharma and Unicycive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Top Crypto Exchanges module to search and analyze digital assets across top global cryptocurrency exchanges.

Other Complementary Tools

Stocks Directory
Find actively traded stocks across global markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences